Bevit Pharmaceuticals Ltd
Ibuprofen (400mg) + Paracetamol (325mg)
Rubigesic P 400 mg/325 mg Tablet is a combination of two painkiller medicines, Ibuprofen and Paracetamol, used to reduce pain, fever, and inflammation.
Tablet
Rubigesic P 400 mg/325 mg Tablet is best taken with food to reduce side effects. The dose and how often you need it will be decided by your doctor. You should take it regularly as advised by your doctor. Medicines used to treat pain are usually best taken at the first sign of pain. It is meant for short-term use only. Consult your doctor if the symptoms persist or worsen or if the medicine is required for use beyond 3 days.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Rubigesic P 400 mg/325 mg Tablet is to be taken with food.
No common side effects listed
It is unsafe to consume alcohol with Rubigesic P 400 mg/325 mg Tablet.
Rubigesic P 400 mg/325 mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Rubigesic P 400 mg/325 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Blood-thinning medicines Medicines for asthma Medicines for liver or kidney problems
Rubigesic P 400 mg/325 mg Tablet is a combination of two medicines: Ibuprofen and Paracetamol. It works by blocking the release of certain chemical messengers that cause fever, pain, and inflammation (redness and swelling).
Take it with food to avoid getting an upset stomach. Take it as per the dose and duration prescribed by your doctor. Long-term use may lead to stomach bleeding and kidney problems. Avoid consuming alcohol when taking Rubigesic P 400 mg/325 mg Tablet as it may cause excessive drowsiness and increase the risk of liver damage. Do not take it with any other medicine containing paracetamol (drugs for pain/fever or cough and cold) without asking your doctor first.
Rubigesic P 400 mg/325 mg Tablet is generally safe for most patients. However, some people may experience unwanted side effects like nausea, vomiting, stomach pain, heartburn, and diarrhea. If you experience persistent problems, inform your doctor.
If you're using the medicine for long-term pain, continue as advised by your doctor. For short-term pain relief, it's usually safe to discontinue use.
Yes, taking Rubigesic P 400 mg/325 mg Tablet may lead to nausea and vomiting. Taking the medication with milk, food, or antacids can help alleviate nausea. Avoid consuming fatty or fried foods while on this medication. If you experience persistent vomiting, talk to your doctor about signs of dehydration, such as dark-colored urine or infrequent urination.
Yes, some patients may feel dizzy (faint, weak, unsteady, or lightheaded) while taking Rubigesic P 400 mg/325 mg Tablet. If you experience dizziness, avoid driving or operating machinery until the symptoms subside.
The use of Rubigesic P 400 mg/325 mg Tablet is not recommended for patients with known allergies to its components, other painkillers (NSAIDs), a history of stomach ulcers, active or recurrent stomach ulcer/bleeding, heart failure, high blood pressure, liver disease, or kidney disease.
No, it is not recommended to take Rubigesic P 400 mg/325 mg Tablet for stomach pain without consulting a doctor. This medication can increase stomach acid secretion and potentially worsen an underlying condition.
Yes, long-term use of Rubigesic P 400 mg/325 mg Tablet may lead to kidney damage due to decreased prostaglandin levels in the body. Patients with underlying kidney disease should not take this medication.
No, taking more than the recommended dose increases the risk of side effects and potential kidney damage. Consult your doctor if you're experiencing increased pain or not getting relief from the recommended doses.